Healthtech Solutions (HLTT)
OTHER OTC:HLTT
US Market
Holding HLTT?
Track your performance easily

Healthtech Solutions (HLTT) Income Statement

10 Followers

Healthtech Solutions Income Statement

Last quarter (Q ), Healthtech Solutions's total revenue was $911.47K, an increase of Infinity% from the same quarter last year. In Q, Healthtech Solutions's net income was $-615.32K. See Healthtech Solutions’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Jun 20Jun 19
Total Revenue
$ 1.69M$ 1.69M---$ 0.00
Cost of Revenue
$ 123.86K$ 123.86K----
Gross Profit
$ 1.56M$ 1.56M----
Operating Expense
$ 5.02M$ 5.02M$ 5.01M$ 709.86K$ 37.49K$ 5.37K
Operating Income
$ -3.46M$ -3.46M$ -5.01M$ -709.86K$ -37.49K$ -5.37K
Net Non Operating Interest Income Expense
--$ -367.14K$ 19.58K--
Other Income Expense
--$ -2.93M$ 2.77K--
Pretax Income
$ -3.46M$ -3.46M$ -8.31M$ -538.93K$ -37.49K$ -5.37K
Tax Provision
---$ -111.00K$ -9.38K$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -3.04M$ -3.04M$ -9.11M$ -1.27M$ -37.49K$ -5.37K
Basic EPS
$ -0.04$ -0.04-$ -0.61-$ >-0.01
Diluted EPS
$ -0.04$ -0.04-$ -0.61-$ >-0.01
Basic Average Shares
$ 202.37M$ 68.07M-$ 1.20M$ 9.70M$ 9.70M
Diluted Average Shares
$ 202.37M$ 68.07M-$ 1.20M$ 9.70M$ 9.70M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 5.14M$ 5.14M$ 5.01M$ 709.86K$ 37.49K$ 5.37K
Net Income From Continuing And Discontinued Operation
$ -3.46M$ -3.46M$ -9.11M$ -732.21K$ -37.49K$ -5.37K
Normalized Income
-----$ -5.37K
Interest Expense
------
EBIT
$ -3.46M$ -3.46M$ -7.94M$ -558.51K$ -37.49K$ -5.37K
EBITDA
$ -3.38M$ -3.38M$ -7.91M$ -673.74K$ -37.49K$ -5.37K
Currency in USD

Healthtech Solutions Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis